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Abstract
Iron is an essential element. However, in its free form, iron participates in redox-reactions, leading to the production of free
radicals that increase oxidative stress and the risk of damaging processes. Living organisms have an efficient mechanism
that regulates iron absorption according to their iron content to protect against oxidative damage. The effects of restricted
and enriched-iron diets on oxidative stress and aging biomarkers were investigated. Adult Wistar rats were fed diets
containing 10, 35 or 350 mg/kg iron (adult restricted-iron, adult control-iron and adult enriched-iron groups, respectively)
for 78 days. Rats aged two months were included as a young control group. Young control group showed higher
hemoglobin and hematocrit values, lower levels of iron and lower levels of MDA or carbonyl in the major studied tissues
than the adult control group. Restricted-iron diet reduced iron concentrations in skeletal muscle and oxidative damage in
the majority of tissues and also increased weight loss. Enriched-iron diet increased hematocrit values, serum iron, gamma-
glutamyl transferase, iron concentrations and oxidative stress in the majority of tissues. As expected, young rats showed
higher mRNA levels of heart and hepatic L-Ferritin (Ftl) and kidneys SMP30 as well as lower mRNA levels of hepatic Hamp
and interleukin-1 beta (Il1b) and also lower levels of liver protein ferritin. Restricted-iron adult rats showed an increase in
heart Ftl mRNA and the enriched-iron adult rats showed an increase in liver nuclear factor erythroid derived 2 like 2 (Nfe2l2)
and Il1b mRNAs and in gut divalent metal transporter-1 mRNA (Slc11a2) relative to the control adult group. These results
suggest that iron supplementation in adult rats may accelerate aging process by increasing oxidative stress while iron
restriction may retards it. However, iron restriction may also impair other physiological processes that are not associated
with aging.
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Introduction
Oxygen radicals produced endogenously during cellular respi-
ration promote the accumulation of oxidative damage in tissues,
resulting in cellular aging [1]. The balance between the production
of reactive oxygen species (ROS) and antioxidant defenses
determines the oxidative state of the body. An increase in the
production of ROS or a reduction in the antioxidant capacity of
the body induces progressive oxidative damage in tissues, leading
to the organ dysfunction that characterizes aging [1,2,3].
According to the theory of the role of free radicals in aging, as
postulated by Denham Harman in the mid-1950s, animals with
high metabolic rates have reduced lifespans.
Due to its chemical versatility, iron was most likely a critical
catalyst for the formation of complex organic compounds in the
primitive environment and then became more commonly used in
modern biological systems [4]. Although iron is an essential
nutrient for health and is involved in several biological processes,
such as erythropoiesis, oxidative metabolism, cellular immune
responses and the regulation of cell growth and differentiation [5],
free iron can potentially become toxic [6,7]. Superoxide radicals
(O2
N2), which are produced via the electron transport chain, may
reduce ferric ions to ferrous ions, which in turn may react with
hydrogen peroxide (H2O2) by the Fenton reaction. This reaction
produces the hydroxyl radical (OHN), which is one of the most
reactive ROS [6]. Iron overload favors the availability of redox-
active labile iron in the tissues and thus the increase of free radical
production and oxidative damage to lipids, proteins and DNA that
may lead to organ dysfunction [7]. The potentially deleterious
effects of iron, in addition to their essential role in animal
biochemical processes, drove the evolution of a molecular system
of proteins that transport iron through membranes such as
divalent metal transporter 1 (DMT-1); transferrin receptor;
ferroportin; ferritin, which stores iron in tissues and transferrin,
which provides iron mobility through the blood circulation in a
safe and available way for the metabolic needs of biological
systems [8,9,10]. Cellular iron content post-transcriptionally
regulates the levels of DMT-1, ferritin, transferrin receptor and
ferroportin by the iron regulatory proteins (IRP1 or IRP2) and the
iron responsive element (IRE) system (IRP/IRE), which are
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untranslated regions of mRNA located in the 59 or 39 end [3,11],
while hepcidin, a hormone primarily synthesized in the liver,
regulates systemic iron homeostasis by adjusting iron absorption
and mobilization in accordance with physiological requirements
[8,10]. However, despite these efficient molecular mechanisms
that control iron homeostasis in the body, tissue iron levels
typically increase with age, presumably due to a failure in the
regulation of iron absorption in enterocytes [12,13].
Several studies have suggested a positive relationship between
the loss of iron homeostasis, the accumulation of oxidative damage
and cellular aging [14,15,16]. Some authors suggest the use of iron
chelation as an alternative therapy for diseases associated with
aging and oxidative stress [17,18,19]. Iron deficiency during the
reproductive period in women maybe the principal factor
responsible for their longevity compared to men, as iron has been
referred to as the malignant spirit of premature aging [18].
Thus, considering that iron accumulation in tissues may be the
causative factor for the accumulated oxidative damage in
senescent cells [5], this work was based on the hypothesis that
chronic oral iron supplementation is harmful and may contribute
to aging. To test this hypothesis, we investigated the effects of the
consumption of enriched and restricted chronic iron diets on
molecular biomarkers of oxidation in tissues and on the expression
of gene aging markers in rats. The specific activity of the enzymes
catalase, glutathione reductase, glutathione peroxidase, glutathi-
one-S-transferase and oxidized NADPH and the levels of lipid
peroxidation and protein carbonylation in tissues were analyzed as
tissue oxidative status biomarkers. Gene level expression of
senescence marker protein (SMP30), ferritin light chain (Ftl) and
the peptide hormone hepcidin (Hamp) were analyzed by
quantitative RT-PCR as markers of aging [12,20,21]. The mRNA
levels of nuclear factor erythroid derived 2 like 2 (Nfe2l2) and
cAMP-responsive element-binding protein H (Creb3l3), both
hepatic transcriptional factors which are responsible for the
oxidative stress in liver were analyzed [22,23,24,25,26]. The
transcript level of Slc11a2 gene that synthesize the divalent metal
transporter – 1 (DMT-1), which is responsible by iron uptake was
also analyzed in gut [27]. The transcript level of interleukin – 1
beta (Il1b) was analyzed as an inflammatory response marker [28].
Materials and Methods
Animals
Twenty adult male Wistar rats (approximately 15 months),
provided by Bioagri’s Laboratory located in Planaltina, Distrito
Federal, Brazil, were divided into three groups of five, seven and
eight animals and housed individually in stainless steel cages at a
temperature of 2262uC under a 12 h light/dark cycle. The rats
had free access to water and food during the dark cycle. The rats
were treated for 78 days (12 weeks) with one of the following diets:
the adult control group received a rodent diet, the AIN-93M diet,
containing 35 mg/kg iron [29]; the adult restricted-iron group
(ARI) received the AIN-93M diet containing 10 mg/kg iron; and
the adult enriched-iron group (AEI) was fed with the AIN-93M
diet containing 350 mg/kg iron. The iron dose in the enriched-
iron diet was estimated from the ‘‘tolerable upper limit intake’’ for
humans (70 kg, adult), adjusting the value proportionally to the
recommendation for rats. The iron dose in the restricted-iron diet
corresponds to the inherent contamination of the diet ingredients,
which is estimated at 30% of the recommendation described for
AIN-93M. Six rats aged 2 months were included as a young
control group one week before sacrifice. After the treatment
period, rats were sacrificed by cervical dislocation, blood samples
was collected by cardiac puncture into two tubes with and without
EDTA 7.0% (21 ml/ml blood) and the organs—liver, spleen,
heart, kidney, skeletal muscle (lower limb) and gut (1-cm length of
small intestine distal to the pylorus and 1-cm proximal to the
ileocecal valve was excised and the lumen was rinsed with saline)—
were excised, washed in a cold 0.9% NaCl solution, rapidly frozen
in liquid nitrogen and stored at 270uC to determine body iron
status and mRNA levels of cAMP responsive element binding
protein H (Creb3l3), hepcidin antimicrobial peptide (Hamp),
ferritin light polypeptide (Ftl), senescence marker protein-30
(SMP30), nuclear factor erythroid derived 2 like 2 (Nfe2l2),
interleukin – 1 beta (Il1b) and the iron divalent metal transporter- 1
(Slc11a2). This protocol was approved by the Ethics Committee for
the Use of Animals of the Institute of Biological Sciences, University
of Brasilia, Brazil as UnBDOC No. 100.199/2009.
Weight record and food intake
The animals were weighed weekly during the treatment. The
consumption of the diet was measured daily by comparing
differences in weight between the amount of food offered and left.
Hematological parameters
Hematological parameters were measured by the SabinH
Laboratory (Distrito Federal, Brazil). Red blood cells, hemoglobin
and hematocrit were analyzed using an automated hematological
analyzer. C-reactive protein concentration (CRP) was measured
using an immunoturbidimetric method, which is based on the
agglutination of latex particles coated with anti-CRP antibodies
when they are mixed with serum containing CRP. Gamma
glutamyl transferase (GGT) activity was determined by kinetic
colorimetric assay. The iron parameters for serum iron, transferrin
saturation and transferrin concentration were determined using
the colorimetric ferrozine-based assay (Goodwin modified).
Tissue iron determination
The concentration of iron in tissues was determined using the
method described by Baranowska et al. (1995) [30]. Briefly,
samples of liver, spleen, heart, kidney, skeletal muscle and gut were
digested with 5 mL concentrated HNO3 (Sigma Aldrich Co., St.
Louis, MO, USA) and 2.5 mL H2SO4 (Sigma Aldrich Co., St.
Louis, MO, USA) in a Provecto Analı´tica Microwave System
(DGT 100 Plus, Jundiai, Sa˜o Paulo, Brazil, 2003). After digestion,
the samples were resuspended in 0.1 mol/L nitric acid to a final
volume of 25 mL. The concentration of iron in the samples was
determined by inductively coupled plasma atomic emission
spectrometry (ICP – AES/Spectro, Kleve, Germany) using a
238 nm line. A calibration curve was obtained for the range from
0 to 10 ppm solution of Fe-Merck Titrisol (Merck, Darmstadt,
Germany) to calculate the concentrations of iron in the tissues.
RNA extraction and reverse transcription-polymerase
chain reaction analysis (qRT-PCR)
The extraction of total RNA from heart, gut, kidney and liver
was performed using Trizol reagent (Invitrogen, Carlsbad, CA,
USA) and chloroform. After extraction, RNA from the aqueous
phase was precipitated using isopropyl alcohol, washed with 70%
ethanol, dried and dissolved in deionized water and stored at
270uC. The integrity of the total RNA was evaluated by
electrophoresis. Briefly, an aliquot of total RNA was subjected to
electrophoresis on a 1% agarose gel with 16TAE running buffer
(Tris: Vetec, Rio de Janeiro, RJ, Brazil; EDTA: Sigma, St. Louis,
MO, USA; acetic acid Vetec) and stained with GreenTM Gel
(Biotium, Hayward, CA, USA). The gel was analyzed using the
software 1D LabImage (Kapelan Bio-Imaging Solutions, Leipzig,
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Germany) to confirm the absence of degraded genetic material.
The concentration and purity of the total RNA samples was
checked by determining the absorbance at 230, 260 and 280 nm
in a spectrophotometer (UV-visible Ultrospec 3000, Pharmacia
Biotech, Cambridge, England) [31]. Verification of the purity of
the RNA samples was performed by assessing the presence of
proteins with the 260/280 nm ratio, while contamination with
aromatic compounds, such as phenol, was assessed with the ratio
260/230 nm. The benchmark used to evaluate these ratios (A260/
A280 and A260/A230) was greater than or equal to 1.8, where
A280 = the spectrophotometric absorbance at a wavelength of
280 nm and A230 = the spectrophotometric absorbance at a
wavelength of 230 nm.
Total RNA was then precipitated using anhydrous sodium
acetate at 3 mol/L and pH 5.2 (0.1 vol) (Sigma, St. Louis, MO,
USA) and 100% ethanol (2.5 vol) at 4uC (Sigma, St. Louis, MO,
USA, 2.5 times the volume 825 mL) and incubated at 220uC
overnight. After incubation, the samples were centrifuged at
100006g at 4uC for 30 min (Centrifuge Eppendorf 5415R,
Hamburg, Germany). Ethanol (1 mL) (Sigma, St. Louis, MO,
USA) was added to the pellet and it was centrifuged at 100006g
for 5 min at 4uC, dried at room temperature and diluted in 20 mL
of deionized water. After this procedure, the absorbance at 230,
260 and 280 nm was determined (UV-visible Ultrospec 3000,
Pharmacia Biotech, Cambridge, England) and the A260/A280
and A260/A230 ratios were again determined to assess the purity
and concentration of the RNA in the treated material. Total RNA
(1 mg) was used for cDNA synthesis reactions using a Reverse
Transcription Kit Improm II System (Promega, Madison, WI,
USA). Oligo (dT) primers were added to the total RNA and
denaturation was performed at 70uC for 5 min. Improm-II
Reverse Transcriptase was added and the samples were incubated
at 42uC for 50 min, followed by inactivation at 70uC for 15 min.
An attempt at cDNA synthesis without the reverse transcriptase
enzyme was performed for each sample (negative control). An
aliquot of the reaction control (no reverse transcriptase) was
subjected to RT-PCR using a reaction system that had been tested
and the oligonucleotide sequences had previously been used by
other authors and described in scientific articles to confirm the
absence of amplified genetic material.
Determination of molecular biomarkers of aging and
oxidative stress
The mRNA concentrations of the aging biomarkers ferritin light
chain (Ftl), SMP30, hepcidin (Hamp), the transcription factor
CREBh (Creb3l3), nuclear factor erythroid derived 2 like 2
(Nfe2l2), interleukin 21 beta (Il1b) and divalent metal transporter
21 (Slc11a2) were quantified using real-time polymerase chain
reaction (qRT-PCR) (7500 Fast Real-Time PCR System, Applied
Biosystems, Foster City, CA, USA). Real-time PCR was carried
out using the Fast SYBR Green Master Mix 2X reagent (Applied
Biosystems, Foster City, CA, USA) with 2 mL of cDNA
(corresponding to 0.2 ng of total RNA) in a final volume of
10 mL with 5 mL Fast SYBR Green Master Mix and 0.2 mmol/L
(final concentration) of each primer. The sequences of the primers
used were designed by other authors: (1) ferritin light chain (Ftl),
forward: CCTACCTCTCTCTGGGCTTCT; reverse:
CTTCTCCTCGGCCAATTC [20]; (2) SMP30, forward: AGG-
CATCAAAGTGTCTGCTGTTT; reverse: GACTGTC-
GAAGTGCCACTGAACT [32]; (3) hepcidin (Hamp), forward:
TGATGCTGAAGCGAAGGA; reverse: TGTGTTGAGAGGT-
CAGGAC [33]; (4) Creb3l3, forward: TCAGAGCCCTTTACC-
CAGACAG; reverse: ATGGTTGGGCTTAGGGTTCAG [22];
(5) nuclear factor erythroid derived 2 like 2 (Nfe2l2), forward:
GAGACGGCCATGACTGAT; reverse: GTGAGGGGATC-
GATGAGTAA [34]; (6) interleukin-1 beta (Il1b), forward:
CACCTCTCAAGCAGAGCACAG; reverse: GGGTTCCATG-
GTGAAGTCAAC [28]; (7) divalent metal transporter-1
(Slc11a2), forward: CTGATTTACAGTCTGGAGCAG; reverse:
CACTTCAGCAAGGTGCAA; and (8) b-actin (Actb), forward:
GTCGTACCACTGGCATTGTG; reverse: CTCTCAGCTG-
TGGTGGTGAA [35]. Dmt-1 primers can amplify iron-respon-
sive element and non–iron-responsive element forms of Dmt-1
cDNA. Quantitative PCR was performed using a 7500 Fast Real-
Time PCR System (Applied Biosystems, Foster City, CA, USA) for
40 cycles at 95uC for 20 s, 60uC for 3 s and 60uC for 20 s. The
amplification specificity of each amplified product was verified
using a melting curve. The efficiency of the qPCR amplification
reactions was evaluated by running standard curves for each
amplicon using different template dilutions of cDNA (1:10, 1:100,
1, 250, 1:500, 1:1000, 1:2000 and 1:10000). The expression of all
genes was normalized to the expression of the housekeeping gene
b-actin (Actb) and the reactions were run in duplicate. The
amplification efficiency was determined from the slope obtained
from the standard curve relating log[transcribed mRNA] and
variation threshold cycle (CT) with the equation E = (1021/slope-
1)6100 and a slope value of the regression line plot of CT values
vs. log of input nucleic acid of approximately 23.32 was
considered an efficient reaction. PCR efficiency was between 91
and 104% for all primers. A standard curve was plotted for each
gene studied that correlated the DCT (CT target - CT reference)
versus the log of the cDNA amount and a slope value of the
regression line plot of DCT values vs. log of input nucleic acid of
less than 0.1 was used as a general criterion to accept the
validation of the experiment. From the data obtained previously, it
had been determined to use a 1:500 dilution of cDNA to analyze
qRT-PCR where the efficiency obtained was higher than 99%.
Melting curve analysis was used to examine the specificity of the
products generated for each primer set. The comparative CT
method was used to quantitate the abundance of target gene
mRNA and is given by 22DDCT. This method was performed as
described in the tutorial ‘‘Guide to Performing Relative Quanti-
tation of Gene Expression Using Real-Time Quantitative PCR’’
(Part #: 4371095 Rev B, Applied Biosystems).
Immunoblot analysis
Rat livers were homogenized in four volumes of 0.25 M
sucrose, 15 mM Tris-HCl (pH 7.9), 15 mM NaCl, 60 mM KCl,
5 mM EDTA, 0.15 mM spermine, 0.5 mM spermidine, 0.1 mM
phenylmethanesulfonyl fluoride, 1.0 mM dithiothreitol and 1%
protease inhibitor cocktail (Sigma Aldrich, St. Louis, MO, USA)
and centrifuged at 120006rpm for ten minutes. The supernatant
was used as an extract [36]. Spot density of ferritin band was
normalized to the amount of protein, by loading equivalent
amount of protein (5 mg), in each lane, for each liver extract
analyzed. Total protein concentration of standard ferritin [37] and
animal’s liver homogenates was determined by the method of
Hartree et al. (1972) [38]. The ferritin light chain protein band has
19 kDa. The proteins were separated by 15% and 5% SDS-PAGE
[31] and transferred to a 0.45 mm polyvinylidene difloride (PVDF)
membrane (ImmobilonH-P transfer membrane – IPVH00010 –
Millipore – Billerica, MA, USA). And as a molecular weight
standard protein was used in each gel and membrane (blot) a
Spectra Multicolor Broad Range Protein Ladder (Thermo
ScientificH) (Data not shown). Blots were first incubated for 1 h
with blocking buffer (containing PBS, 0.1% Tween 20 and 5%
nonfat dry milk) and then incubated with primary antibodies for
1 h at room temperature. Primary antibodies were used at a
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dilution of 1:1000 for goat anti-FTL (SAB2500431 – Sigma
Aldrich, St Louis, MO, USA). Blots were then washed three times
in 0.1% PBS-T (Phosphate Buffered Saline with Tween 20) and
incubated for 1 h at room temperature with 1:3000 diluted anti-
goat IgG alkaline phosphatase-conjugated secondary antibodies
(A4187 - Sigma Aldrich, St Louis, MO, USA) and signals were
visualized with BCIPH/NBT solution (B6404 – Sigma Aldrich, St
Louis, MO, USA).
Lipid peroxidation
The malondialdehyde (MDA) concentrations in liver, spleen,
heart, skeletal muscle, gut and kidney homogenates were
measured by high performance liquid chromatography (25 cm
Shim-park C18 CLC-ODS (M) column Shimadzu, Kyoto, Japan
– heart and kidney; and 15 cm Shim-park C18 CLC-ODS (M)
column Shimadzu, Kyoto, Japan – liver, spleen, gut and skeletal
muscle) [39]. The spectrofluorometric detector wavelengths were
set at 532 nm (excitation) and 553 nm (emission). A four-point
standard curve (0.81–16.16 nmol/mL) was made with tetraethox-
ypropane (TEP) (Sigma, St. Louis, MO, USA) dissolved in 1%
H2SO4, as acid hydrolysis of TEP yields stoichiometric amounts of
MDA (column 15 cm: y = 7.102762 0.132; r2 = 0.9903 and
column 25 cm: y = 7.10266+ 0.0473; r2 = 0.9974). Total homog-
enate protein concentration was determined by the method of
Hartree et al. (1972) [38]. The results were expressed as nmol
MDA/mg total protein [38].
Protein oxidation
Protein oxidation of liver, spleen, kidney, heart, gut and skeletal
muscle homogenates was measured by carbonyl content according
to the method of Richert et al. (2002) [40]. Absorbance was
measured at 376 nm (spectrophotometer Shimadzu – TCC 240A)
and carbonyl content was expressed as nmol of carbonyl groups
per milligrams of total protein using an extinction coefficient of
22 mmol?L21?cm21. Total homogenate protein concentration
was determined by the method of Hartree et al. (1972) [38].
Preparation of tissue homogenates for enzyme assays
Liver, spleen, heart, gut, kidney and skeletal muscle tissues were
homogenized at 1:20 (w/v) in an Ultraturrax homogenizer using
0.5 mol/L of potassium phosphate buffer, pH 7.2, containing
50 mmol/L of ethylenediaminetetra-acetic acid and 1 mmol/L of
phenylmethylsulfonyl fluoride (Sigma Aldrich, St. Louis, MO,
USA) at 4uC and centrifuged at 15 0006g for 20 min.
Catalase assay
The activity of catalase was quantified by the consumption of
10 mmol/L of H2O2 at 240 nm (spectrophotometer Shimadzu –
TCC 240A) in buffer containing 10–50 mL of tissue homogenates
[41,42]. Blanks were run without H2O2. One unit of catalase was
defined as the amount of enzyme required to decompose 1 mmol
of H2O2/min.
Glutathione peroxidase assay
Glutathione peroxidase activity was quantified using H2O2 as a
substrate in a coupled assay with Glutathione Reductase-catalyzed
oxidation of nicotinamide adenine dinucleotide phosphate
(NADPH) at 340 nm (spectrophotometer Shimadzu - TCC
240A) [42]. First, the basal consumption of 0.15 mmol/L of
nicotinamide adenine dinucleotide phosphate was measured in
buffer containing 2 mmol/L of azide, 5 mmol/L of glutathione
(GSH), 1.5 U of glutathione reductase and 10–50 mL of tissue
homogenates. Then, 20 mL of H2O2 was added to a final
concentration of 0.2 mmol/L. Blanks were run without tissue
homogenate [43]. One unit of glutathione peroxidase was defined
as the amount of enzyme required to oxidize 1 nmol of
nicotinamide adenine dinucleotide phosphate/min.
Glutathione Reductase assay
Glutathione reductase activity was quantified by spectropho-
tometry (spectrophotometer Shimadzu - TCC 240A) at 340 nm,
where the oxidation of nicotinamide adenine dinucleotide
phosphate was monitored for 20 seconds [42]. Tissue homogenate
activity (75–250 mL) was measured in 50 mmol/L of potassium
phosphate buffer (pH 7.2) containing 0.5 mmol/L of ethylenedia-
minetetra-acetic acid, 0.2 mmol/L of nicotinamide adenine
dinucleotide phosphate and 1 mmol/L of glutathione oxidized
(GSSG). Blanks were run only with GSSG. One unit of
glutathione reductase was defined as the amount of enzyme
required to oxidize 1 nmol of nicotinamide adenine dinucleotide
phosphate/min.
Glutathione-S-transferase assay
Glutathione-S-transferase (GST) activity was measured by
following the conjugation of 1 mmol/L of GSH with 1 mmol/L
of 1-chloro-2,4-dinitrobenzene [42] at 340 nm (spectrophotometer
Shimadzu – TCC 240A) in 50 mmol/L of potassium phosphate
buffer (pH 7.2) containing 50 mL of tissue homogenate [44]. One
unit of GST was the amount of enzyme required to yield 1 nmol
of product/min.
NADPH oxidation assay
Nicotinamide adenine dinucleotide phosphate oxidase activity
was measured by quantifying the consumption of NADPH by
spectrophotometry (spectrophotometer Shimadzu - TCC 240A) at
340 nm [45]. The assay was monitored over 300 seconds and the
assay buffer contained 50 mmol/L of potassium phosphate buffer
(pH 7.2) with 0.5 mmol/L of ethylenediaminetetra-acetic acid,
0.1 mmol/L of nicotinamide adenine dinucleotide phosphate and
125–250 mL of tissue homogenate. One unit of NADPH oxidized
was the amount of enzyme required to oxidize 1 nmol of
NADPH/min.
Statistical Analysis
Comparisons among the treatments in each group were tested
by independent sample test t-test for equality of means using SPSS
version 17 software (SPSS Inc., Chicago, USA). In all tests, a value
of P,0.05 was considered statistically significant.
Results
Table 1 shows the food and iron intake and the initial and final
body weight of animals during the 78 days of treatment (12 weeks).
There was no significant difference in food intake among the three
groups of rats. As expected, ARI rats showed the lowest iron intake
(p,0.001) and the AEI rats showed the highest intake of iron
(p,0.001) compared to control rats. The adult rats from the three
groups showed weight loss at the end of the treatment period
relative to the initial time, however restricted-iron rats showed
greater weight loss than control rats (p = 0.024).
The young group showed significantly higher hemoglobin
concentrations (p = 0.006) and hematocrit levels (p = 0.001) than
the control rats. Hematocrit levels were higher in the restricted-
iron dietary group than in the control group (p = 0.036). The
enriched-iron group showed higher hematocrit, serum iron and
gamma glutamyl transferase levels (p = 0.025; p = 0.005 and
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p = 0.019, respectively) and lower C-reactive protein levels
(p = 0.047) relative to the control group (Table 2).
The younger rats showed lower iron concentrations in liver,
spleen, kidney and skeletal muscle relative to the control group
(p = 0.001; p = 0.002; p,0.001 and p,0.001, respectively).
Among the adult rats, the restricted-iron group only showed a
reduction in iron concentration in skeletal muscle compared with
the control group (p = 0.001) and no significant difference was
observed in the iron concentrations of the other tissues. The livers,
spleens and guts of the rats from the enriched-iron group showed
higher iron concentrations (p = 0.005; p = 0.008 and p = 0.042,
respectively), while in skeletal muscle this value was lower relative
to the control group (p,0.001) (Figure 1).
Figure 2 shows the relative transcript levels of senescence
marker protein 30 (SMP30), ferritin light chain (Ftl), hepcidin
(Hamp), Creb3l3, nuclear factor erythroid derived 2 like 2 (Nfe2l2)
and interleukin-1 beta (Il1b) in rat livers normalized to values
obtained for b-actin (Actb). Young rats showed higher levels of
hepatic ferritin light chain (Ftl) mRNA (p = 0.007), lower levels of
hepcidin (Hamp) and interleukin-1 beta (Il1b) mRNAs (p = 0.008
and p = 0.004, respectively) compared to the control rats. There
was no difference in the levels of hepatic SMP30 and Creb3l3
transcripts between the young and control groups. Higher
transcript levels of Nfe2l2 and Il1b were found in the enriched-
iron group relative to the control group (p = 0.009 and p = 0.001,
respectively).
The mRNA levels of Ftl, SMP30 and Slc11a2 were also
analyzed in heart, kidney and gut, respectively, and the relative
values are presented in Figure 3. The young group showed higher
levels of kidney SMP30 transcripts and higher heart Ftl transcripts
relative to the control group (p = 0.033 and 0.022, respectively).
Among the adult groups, ARI rats showed higher levels of heart
Ftl mRNA and a marginal reduction in the levels of kidney
SMP30 mRNA relative to the control group (p,0.001 and 0.060,
respectively). The AEI rats showed higher levels of gut Slc11a2
mRNA than the control group (p,0.001). There was no difference
in heart Ftl and kidney SMP30 mRNA levels between the AEI and
control groups (Figure 3).
Ferritin light chain protein levels were analyzed by Western blot
in the livers of rats from all groups and the results are shown in
Figure 4. A significant difference was only found for young rats,
which showed lower levels of ferritin protein compared to the
control group (p = 0.046).
Figure 5 shows the oxidative state of the rats, which was
evaluated by measuring carbonyl and MDA levels in rat tissues.
The young group showed significantly lower levels of MDA in
liver, spleen and heart and higher levels in skeletal muscle relative
to the control group. Young rats also showed lower carbonyl levels
in gut; however, higher levels were found in the heart. Restricted-
iron diet rats showed a significant reduction in MDA levels in liver,
heart, kidney and gut and a significant increase in MDA levels in
spleen relative to control rats. Carbonyl levels were also
significantly lower in the livers of ARI rats than control rats, but
increased carbonyl levels were observed in skeletal muscle. The
enriched-iron (AEI) rats showed a significant increase in MDA
levels in spleen and gut and a significant reduction in heart tissue.
Liver, heart and skeletal muscle of the AEI rats showed higher
carbonyl levels than control rats (Figure 5).
The oxidative status of young and adult rats was also measured
by analyzing the specific enzymatic activities of catalase (CAT),
glutathione reductase (GR), glutathione peroxidase (GPx), gluta-
thione S-transferase (GST) and NADPH oxidase (Nox) and the
results are shown in Figure 6. There were changes in specific
enzymatic activities in some tissues. Catalase activity was higher in
liver and kidney, GPx activity was higher in liver, spleen, heart and
kidney, GR activity was higher in kidney and gut, GST activity
was higher in liver, kidney and gut and Nox activity was higher in
Table 1. Food intake, iron intake, initial and final body weight
of adult rats treated with control and restricted-iron (ARI) or
enriched-iron (AEI) diets during a 78-day treatment period.
Control ARI AEI
Food intake (kg) 1.8360.04 1.6860.16 1.7960.09
Iron intake (mg) 64.2261.13 16.8161.60 (***) 627.64634.29 (***)
Initial body weight (g) 526.52642.45 510.75679.97 514.62639.38
Final body weight (g) 496.91631.32 446.28668.89 471.85648.56
Average and standard deviation: n = 7 (CT); n = 5 (ARI); n = 8 (AEI). Difference





Table 2. Hematological parameters of adult rats treated with control and restricted-iron (ARI) or enriched-iron (AEI) diets and of
young rats.
Young Control ARI AEI
Erythrocytes (million/mm3) 8.8260.34 8.6260.48 8.9060.68 8.7560.39
Hemoglobin (g/dL) 17.360.9 (**) 15.860.5 16.560.6 16.260.8
Hematocrit (%) 51.663.2 (***) 45.161.0 47.461.7 (*) 46.761.2 (*)
Serum Iron (mg/dL) 2426106 226634 164699 346678 (**)
Transferrin saturation (%) 58.9622.3 63.7619.8 39.6623.6 75.2613.2
Transferrin (mg/dL) 282622 283649 294625 320632
C-Reactive Protein (mg/dL) 0.3360.11 (*) 0.4860.06 0.5660.12 0.3860.11 (*)
Gamma glutamyl transferase (U/L) 362 160 160 765 (*)
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spleen, gut and skeletal muscle. Young rats showed significantly lower
levels of CAT activity in spleen, while GR activity was lower in spleen
and kidney, GPx activity was lower in spleen, heart and kidney and
Nox activity was lower in spleen relative to control rats. The ARI rats
only showed differences in the activity of two antioxidant enzymes:
GPx in spleen and Nox in liver were higher than the levels found in
control rats. AEI rats showed high levels of CAT activity in gut and
there was lower activity for GR in kidney, GST in gut and Nox in
spleen and gut compared to control rats (Figure 6).
Discussion
Oxidative stress and aging are related to the decline in the
repair mechanisms for molecular oxidative damage, which can
Figure 1. Concentration of iron in the tissues of adult rats treated with control and restricted-iron (ARI) or enriched-iron (AEI) diets
and of young rats (mg of iron/g tissue). Average and standard deviation: n = 7 (CT); n = 5 (ARI); n = 8 (AEI); n = 6 (young). Difference between
control group and test groups: *p#0.05; **p#0.01; ***p#0.001 (Student’s t-test).
doi:10.1371/journal.pone.0061058.g001
Figure 2. Quantification of SMP30, Ferritin (Ftl), Hepcidin (Hamp), Creb3l3, Nuclear factor erythroid derived 2 like 2 (Nfe2l2) and
interleukin-1 beta (Il1b) mRNA from the livers of adult rats treated with control and restricted-iron (ARI) or enriched-iron (AEI) diets
and of young rats (Gene/b-actin mRNA ratio - fold change). Average and standard deviation: n = 7 (CT); n = 5 (ARI); n = 8 (AEI); n = 6 (young).
Difference between control group and test groups: *p#0.05; **p#0.01; ***p#0.001 (Student’s t-test). RT-PCR analyses were normalized against the
mRNA expression of the housekeeping gene (b-actin gene) in the same tissue sample and then expressed as the ‘‘test/control’’ ratios.
doi:10.1371/journal.pone.0061058.g002
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cause cellular dysfunction, compromising organ function and,
consequently, organism life span [13]. Free iron in the body
generates oxidative stress, and, therefore, an excess of iron in the
body might accelerate the aging process [13,46]. To test this
hypothesis in the present study, adult Wistar rats (15 months of
age) were treated with diets containing adequate levels of iron
(adult control group), restricted-iron levels (ARI group) and
enriched-iron levels (AEI group) to verify the effects of dietary
iron content on iron status, oxidative stress and on aging markers
in rat tissues. Wistar rats aged two months constituted a young
control group for comparison with the data obtained from adult
rats.
Tissue iron accumulation in senescent animals and humans
seems to be a result of an increase in inflammatory processes
during the aging [12,17,18,47,48]. Actually, the cytokines IL1b
and IL6 induce hepatic synthesis of hepcidin [10], an antimicro-
bial hormone, which, once secreted into the bloodstream [49,50],
reduces intestinal iron absorption and prevents iron exportation
from macrophages of the spleen to the bloodstream [8,10]. Thus,
high levels of hepcidin impair iron mobilization, leading to iron
accumulation in tissues such as the spleen and liver [33,51]. Iron
overload in the tissues of patients with chronic diseases such as
renal failure, or diseases of aging, such as Parkinson’s [52],
supports the hypothesis that excess iron in an organism is involved
in the pathology of the aging process. Moreover, reduced iron
mobilization by the hormone hepcidin impairs several physiolog-
ical processes that are iron-dependent, such as erythropoiesis [49],
which may lead to anemia.
In the present study, rats at 15 months of age were considered
adult rats, while rats at 2 months of age were considered young.
However, the weight loss observed during the 78-day treatment, as
well as the reductions in hemoglobin concentrations and
hematocrit values found in rats from the 15-month control group
compared to young rats, are characteristic of the senile stage of the
first group (Table 1 and 2) according to the results reported by
Arvapalli et al. (2010) [17].
The adult rats of the control group showed higher values of
serum C-reactive protein (CRP) (Table 2) and higher levels of
hepcidin transcripts (Figure 2) associated with increased iron in
liver, spleen, kidney and skeletal muscle (Figure 1) and they also
showed lower hemoglobin and hematocrit levels (Table 2) relative
to young rats. Moreover, adult rats had higher level of interleukin-
1 beta mRNA (Il1b) (Figure 2), a pro-inflammatory cytokine that
up regulates liver hepcidin [53]. An activation of the innate
immune system and the presence of low-grade inflammation is a
common hallmark of the aging process [54]. Put all together, these
results corroborate with the hypothesis that the induction of
hepcidin transcription could be responsible for the reduction in
iron mobilization in adult rats, resulting in iron tissue accumula-
tion and consequently, a reduction of erythropoiesis.
In accordance with the hypothesis that oxidative stress is
associated with the aging process [55], young rats had lower levels
of oxidative damage to lipids in the liver, spleen and heart
compared to adult control rats. The higher levels of oxidative
damage to heart proteins and skeletal muscle lipids found in the
young rats (Figure 5) that were apparently contrary to the Harman
hypothesis, could be explained by the high metabolic and physical
activities of the young rats compared to the adult rats.
The lower specific activities of the antioxidant enzymes CAT,
GR and GPx and the Nox enzyme that were observed in some
tissues of young rats compared to adult rats (Figure 6) is in
agreement with findings in the literature. Researchers observed an
increase in GPx activity in the livers of aged male mice [56]. Some
authors have found increased CAT and GPx activity during the
first 18 months of life in rats and mice, but these values decreased
significantly at 24 months of age [56,57]. Similar to results from
rat spleens, shown in Figure 6, reduced levels of Nox in young rats
have been reported in the literature [58,59,60]. Together, these
Figure 3. Quantification of Ferritin (Ftl) mRNA from heart tissue, SMP30 mRNA from kidney tissue and divalent metal transporter-1
(Slc11a2) mRNA from gut tissue of adult rats treated with control and restricted-iron (ARI) or enriched-iron (AEI) diets and of young
rats (Gene/b-actin mRNA ratio - fold change). Average and standard deviation: n = 7 (CT); n = 5 (ARI); n = 8 (AEI); n = 6 (young). Difference
between control group and test groups: *p#0.05; **p#0.01; ***p#0.001 (Student’s t-test). RT-PCR analyses were normalized against the mRNA
expression of the housekeeping gene (b-actin gene) in the same tissue sample and then expressed as the ‘‘test/control’’ ratios.
doi:10.1371/journal.pone.0061058.g003
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Figure 4. Western Blot analysis of Ferritin Light Chain (19 kDa) protein expression in liver (5 mg) from adult rats treated with
control and restricted-iron (ARI) or enriched-iron (AEI) diets and in young rats. Average and standard deviation: n = 7 (CT); n = 5 (ARI); n = 8
(AEI); n = 6 (young). Difference between control group and test groups: *p#0.05; **p#0.01; ***p#0.001 (Student’s t-test).
doi:10.1371/journal.pone.0061058.g004
Figure 5. Malondialdehyde (MDA) (A) and protein carbonyl concentration (B) in liver, spleen, heart, kidney, gut and skeletal muscle
homogenates of young rats and adult rats treated with control and restricted-iron (ARI) or enriched-iron (AEI) diets (nmols MDA/
mg of protein and nmols carbonyl/mg of protein). Average and standard deviation: n = 7 (CT); n = 5 (ARI); n = 8 (AEI); n = 6 (young). Difference
between control group and test groups:*p#0.05; **p#0.01; ***p#0.001 (Student’s t-test).
doi:10.1371/journal.pone.0061058.g005
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results suggest that levels of the specific activities of antioxidant
enzymes tend to increase with the age.
The role of dietary iron in the aging process is not fully
explored. The deleterious effects of dietary iron seem not to be due
to high iron intake but rather to abnormal cellular iron
metabolism, trafficking or storage [61]. Surprisingly, adult rats
submitted to the restricted-iron diet (ARI) after 12 weeks of
treatment showed a significant reduction in iron content only in
Figure 6. Specific activity of catalase (A), GR (B), GPX (C), GST (D) and Nox (E) from tissue homogenates of adult rats treated with
control and restricted-iron (ARI) or enriched-iron (AEI) diets and of young rats (U/mg of protein). Average and standard deviation: n = 7
(CT); n = 5 (ARI); n = 8 (AEI); n = 6 (young). Difference between control group and test groups:*p#0.05; **p#0.01; ***p#0.001 (Student’s t-test). GR,
glutathione reductase; GPX, glutathione peroxidase; GST, glutathione-S-transferase; Nox, Nicotinamide adenine dinucleotide phosphate oxidase.
doi:10.1371/journal.pone.0061058.g006
Dietary Iron on Aging Process
PLOS ONE | www.plosone.org 9 April 2013 | Volume 8 | Issue 4 | e61058
skeletal muscle compared to the control group. This result suggests
that the iron that accumulates in tissues with age can be found
predominantly in the hemosiderin complex in an iron redox-
inactive form [13], which protects tissues against the oxidative
stress induced by iron [62]; however, this iron form is not
bioavailable for physiological functions. If so, it is expected that a
chronic reduction in dietary iron would induce anemia in rats.
The ARI rats did not show anemia, but instead they showed
higher hematocrit levels than the control group. These results may
be due to the effect of hemoconcentration because these animals
lost more weight compared to control rats.
Although a reduction in iron concentration was observed only
in skeletal muscle, the consumption of a restricted-iron diet
contributed to the significant reduction in oxidative damage to
lipids (MDA) in liver, heart, kidney and gut and a reduction in
carbonyl levels in the livers of ARI rats. A similar result was
obtained in a recent study conducted in young rats, in which it was
observed that dietary restriction of iron reduced the production of
superoxide and lipid peroxide levels in the liver, pancreas and
plasma [63]. Thus, except for the increased oxidative damage to
lipids and proteins observed in the spleen and muscle, respectively,
the data obtained from the other organs of the rats with the
restricted-iron diet correlates with evidence reported in the
literature and corroborates the thesis that iron deprivation or
dietary iron chelation therapy may be effective in treating or
preventing oxidative stress and thus retard the aging process [18].
However, one must consider that iron accumulated in the tissues
of the elderly may be predominantly stored in hemosiderin
complexes and is therefore unavailable to meet physiological
demands. A marginal reduction was observed in the transferrin
saturation values of the ARI rats compared to control rats
(p = 0.0840), suggesting a reduction in iron mobilization in these
rats. Thus, both iron restriction and the use of chelating agents
may reduce the amount of bioavailable iron, which could impair
several cellular processes and tissue functions. The reduced iron
levels associated with higher body weight loss (Figure 1, Table 1)
and the increased oxidative damage to proteins (Figures 1 and 5
and Table 1) observed in the skeletal muscle of ARI rats suggest a
more pronounced loss of muscle, most likely due to the depletion
of bioavailable iron in these animals.
In the other hand, the increased values of hematocrit, serum
iron and iron concentration in liver, spleen and gut (Table 2 and
Figure 1) found in the adult enriched-iron group, indicate an
increased absorption of dietary non-heme iron in these rats. These
results, in association with increased oxidative stress (Figure 5), as
evidenced by increased serum levels of gamma glutamyl transfer-
ase (Table 2), MDA in spleen and gut (Figure 5) and carbonyl in
liver, heart and skeletal muscle (Figure 5), suggest that dietary iron
supplementation leads to tissue iron overload and also increase
oxidative stress in tissues, despite the thin molecular mechanism of
gut iron absorption regulation that is synchronized with physio-
logical demands [8].
Ferritin levels in tissues indeed increase during the aging process
[62,64]. In mammals, most non-heme iron is linked to ferritin, a
molecule that consists of two types of polypeptide chain, light (L)
and heavy (H), whose function is to reduce the intracellular labile
iron pool, minimizing production of ROS [21] and, therefore,
protecting cellular components against oxidative damage
[11,62,64,65]. The expression of ferritin in tissues is translationally
regulated by labile intracellular iron through the IRP/IRE system
(for review see [11,66]).
As expected, Western blot results showed that young rats had
lower levels of hepatic L-ferritin protein (Figure 4), while the
mRNA levels of L-ferritin (Ftl) in the livers and hearts of young
rats were significantly higher compared to adult rats of the control
group (Figure 2 and 3). A similar result was also observed in the
livers of young rats (2 months) compared to aged rats (24 months)
in a study by Bulvik et al. (2012) [62]. These results, suggest that,
in addition to the major role of ferritin in the reduction of
intracellular labile iron, the L-ferritin mRNA molecule is also
stabilized by the IRP/IRE system at low intracellular iron
concentrations. Specifically, although cells with low iron content
do not synthesize L-ferritin protein due to the binding of IRP to 59
IREs, L-ferritin mRNA molecules should be maintained intracel-
lularly to allow the immediate translation of ferritin. This strategy
would quickly prevent increases in cellular oxidative stress when
cells are exposed to high concentrations of iron. The increase of
the heart Ftl mRNA levels found for the adult restricted-iron rats
(Figure 3) corroborate with this thesis.
In higher animals, hepatic levels of SMP30 protein decrease
during the aging process [21,67,68,69]. SMP30 is a protein that is
predominantly synthesized by the liver and kidneys with highly
conserved amino acid sequences among various animal species,
including humans. Although its genuine function in humans is still
unknown, studies in a human hepatoma cell line suggest that
SMP30 regulates the levels of cytoplasmic Ca2+ through the
modulation of sodium-independent Ca2+-pumping activity in
plasma membranes. In rats, this protein participates in the
synthesis of vitamin C [68] and appears to protect cells against
apoptosis and other lesions [70], moreover there is a negative
correlation between the expression of SMP30 and levels of reactive
oxygen species in the liver and kidneys of mice [69]. Thus, the
reduction of SMP30 with aging appears to be associated for the
senescent fragility that contributes to the deterioration of cellular
functions. In agreement with the literature, young rats showed
higher levels of SMP30 transcripts in the kidney compared to adult
rats. Interestingly, rats treated with the restricted-iron diet, which,
despite the reduction in oxidative damage to lipids, showed a
marginal reduction (p = 0.060) in kidney SMP30 levels compared
to control rats.
Cells have several molecular defense mechanisms against
oxidative stress. CREBh, a hepatocyte-specific transcription factor
belonging to the cyclic AMP response element binding protein
transcription factor (CREB/ATF) family [71,72] is activated by
endoplasmic reticulum stress. Once activated, CREBh regulates
iron metabolism through the induction of hepcidin [50], and it is
also required to induce the expression of serum amyloid
P-component and C-reactive protein, which are both involved in
the acute phase response [73]. The oxidative stress are also
regulated by the transcription nuclear factor erythroid derived 2
like 2 (Nfe2l2) in multiple cell types and tissues, including the liver
[25,26]. Nfe2l2 controls the basal and induced expression of an
array of antioxidant responsive element-dependent genes that
regulate the physiological and pathophysiological outcomes of
oxidant exposure [25]. In the present study, although there were no
changes in the levels of hepatic Creb3l3 and Nfe2l2 mRNAs, young
rats showed lower hepatic oxidative stress and also lower serum
CRP and liver mRNA Hamp levels in comparison to adult rats.
The result regarding the transcript factor nuclear factor
erythroid derived 2 like 2 (Nfe2l2) found in the liver of iron
supplemented rats associated with the high levels of hepatic iron
strengthens the previous findings that elevated hepatic iron levels
induce oxidative stress [26] once these animals showed the higher
transcript levels of Nfe2l2 and higher iron concentration relative to
the control group (Figure 2). In the other hand, the highest value
of liver Il1b mRNA level also found in the enriched-iron rats
suggest an enhanced of inflammatory process. These results
support the role of hepatic oxidative stress in the acute phase
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response and iron metabolism and also indicate a link between
aging, oxidative stress and inflammatory processes. The appar-
ently contradictory result found in the enriched-iron rats, which
showed lower CRP levels than the control rats (p = 0.047), may,
actually, reflects a liver dysfunction as a consequence of the
increase in oxidative stress, as evidenced by the increased of
carbonyl protein in the liver of these rats (Figure 5B).
In regard to the systemic iron regulation the young rats showed
lower Hamp mRNA levels relative to the control group, however
there was no significant difference among the three adult groups.
This finding should be due to the putative saturable physiological
response of the hepcidin recently postulated by Daba et al. (2013)
[74]. The high iron concentration found in the adult rats, may be
higher than the hepcidin saturation response. Thus it may not
respond any more to serum and liver iron concentration changes,
resulting in the impairment of the systemic iron homeostasis. The
saturable hepcidin response may explain the changes in iron
tissues and in the oxidative status of the adult rats, which were
proportional to the amount of iron in the diets. Considering the
recently findings that hepcidin inhibits the expression of Dmt1
[75] we also analyzed the Dmt1 transcripts levels (Slc11a2) in the
gut of the rats (Figure 3). Surprisingly, although the mRNA level of
hepcidin did not change among the adult groups, the enriched-
iron rats showed higher transcript levels of Slc11a2 (Dmt1) than
control group. This result suggests another systemic regulatory
mechanism of iron absorption hepcidin-independent. A recent
study showed that the proinflammatory cytokine IL-1b induces
divalent metal transporter 1 (Dmt1) expression [76]. In the present
study, the supplemented rats showed also higher levels of mRNA
for Il1b. Taken together, it is possible that increased levels of
Slc11a2 (Dmt1) are due to inflammatory process.
Conclusion
Despite the molecular mechanisms for the regulation of iron
absorption, the chronic consumption of a diet with high iron
content by adult rats resulted in the accumulation of iron in the
liver, spleen and gut, increased oxidative stress in the majority of
studied tissues and reduced the activity of some antioxidant
enzymes. Although the restriction of dietary iron only reduced iron
levels in skeletal muscle, with the exception of spleen and muscle, it
protected the other studied tissues against oxidative damage to
lipids and proteins and resulted in increased activity of GPx in
spleen. However, dietary restriction of iron also caused higher
weight loss, increased oxidative stress in muscle and spleen and
resulted in high activity of Nox in liver of adult rats. The results of
this study indicated that iron supplementation may accelerate
aging processes by increasing tissues oxidative damages, while iron
restriction may retard. However, iron restriction may also impair
other physiological processes that are not associated with aging.
Considering the limitations of the animal model used in this study,
the treatment of elderly patients with iron chelators could reduce
oxidative stress in some tissues but could also lead to cell
dysfunction due to the depletion of bioavailable iron. On the
other hand, the iron fortification of several foods, which occurs in
various countries, may increase oxidative stress and, consequently,
compromise both the quality and the life expectancy meanly of
elderly populations. In conclusion, adult organism may be more
vulnerable to changes in the concentrations of dietary iron than
young, because they lose their capacity to control the iron
absorption by the modulation of hepcidin levels.
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